Abstract:Abstract Background: Alzheimer’s disease (AD) is pathologically characterized by extracellular deposition of amyloid β peptide (Aβ), intracellular neurofibrillary tangles (composed mainly of phosphorylated tau [p-tau]) and neuroinflammation. The pathogenic role of inflammatory activation in AD has been extensively studied; however, the underlying mechanisms remain unclear. In this project, we investigated how neuronal IKKβ/NF-kB regulates AD-associated pathologies in APP- and tau-transgenic AD mice. Methods: APP- and tau-transgenic mice were cross-bred with ikbkb-floxed and nex-cre knock-in mice to generate AD models with deletion of IKKβ specifically in neurons. After assessing cognitive function with the Morris water maze test, mice were analyzed for Aβ and p-tau levels, microglial numbers, transcription of inflammatory genes, apoptosis and synaptic protein levels in the brain by histological, biochemical and molecular biology methods. To explore pathogenic mechanisms, we analyzed the activity and/or protein levels of: 1) β- and γ-secretases, 2) tau-phosphorylating (e.g., GSK3β and p38α-MAPK) and dephosphorylating enzymes (e.g., PP2A and PP2B), and 3) autophagy-related proteins (e.g., LC3B, beclin1 and SQSTM1/p62). In addition, IKKβ-knockdown and wild-type SH-SY5Y cell lines were created to verify the in vivo results.Results: In APP-transgenic mice, neuronal deficiency of IKKβ decreased Aβ load, inflammatory activation, and apoptosis in the brain, and improved cognitive function and maintenance of synaptic proteins (e.g., PSD-95). IKKβ deficiency decreased BACE1 activity and protein in the brain and cultured neuronal cells. In tau-transgenic mice, neuronal deficiency of IKKβ decreased p-tau, shifted pro- to anti-inflammatory activation and inhibited autophagy in the brain. IKKβ deficiency increased expression of PP2A catalytic subunit isoform A, an enzyme dephosphorylating cerebral p-tau. However, deficiency of IKKβ in neurons did not alter the cognitive function and even increased apoptosis in the brain.Conclusions: Deficiency of IKKβ in neurons attenuates Aβ and p-tau loads in the brains of AD mice. As possible molecular mechanisms, IKKβ deficiency decreases BACE1 activity, thereby reducing Aβ production, and increases PP2A expression, promoting p-tau dephosphorylation. However, IKKβ deficiency protects neurons only in APP-transgenic mice, but not in tau-transgenic AD mice. Further studies are needed before IKKβ/NF-kB can be targeted for AD therapies.

Neuregulin1beta1 Antagonizes Apoptosis Via Erbb4-Dependent Activation of Pi3-Kinase/Akt in App/Ps1 Transgenic Mice

Ginsenoside Rg1 Exerts a Protective Effect Against Aβ₂₅₋₃₅-induced Toxicity in Primary Cultured Rat Cortical Neurons Through the NF-κB/NO Pathway.

Neuregulin1β1 protects oligodendrocyte progenitor cells from oxygen glucose deprivation injury induced apoptosis via ErbB4-dependent activation of PI3-kinase/Akt.

Neuroglobin Attenuates Beta Amyloid-Induced Apoptosis Through Inhibiting Caspases Activity by Activating PI3K/Akt Signaling Pathway

App Regulates Ngf Receptor Trafficking And Ngf-Mediated Neuronal Differentiation And Survival

Neuregulin 1 Improves Cognitive Deficits and Neuropathology in an Alzheimer'S Disease Model

Inhibition of PTEN Attenuates Endoplasmic Reticulum Stress and Apoptosis Via Activation of PI3K/AKT Pathway in Alzheimer’s Disease

NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-beta(42) by Inhibiting GSK3 beta Activation in N2a/APP695swe Cells

Deficiency of IKKβ in neurons ameliorates Alzheimer’s disease pathology in APP- and tau-transgenic mice

[Ginsenoside Rg1 antagonizes β-amyloid peptide-induced apoptosis in primarily cultured rat neurons via mitochondrial pathway].

Amyloid-β Induces NLRP1-Dependent Neuronal Pyroptosis in Alzheimer's Disease (P1.239)

Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model

Notoginsenoside R1 Attenuates Amyloid-Β-induced Damage in Neurons by Inhibiting Reactive Oxygen Species and Modulating MAPK Activation

NDRG4 Alleviates Aβ1–40 Induction of SH-SY5Y Cell Injury Via Activation of BDNF-Inducing Signalling Pathways

Ginsenoside Rg1 Protection Against Β-Amyloid Peptide-Induced Neuronal Apoptosis Via Estrogen Receptor Α and Glucocorticoid Receptor-Dependent Anti-Protein Nitration Pathway.

Neuregulins in Neurodegenerative Diseases

Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice

NLRC3 Delays the Progression of AD in APP/PS1 Mice Via Inhibiting PI3K Activation

Interfering Effect and Mechanism of Neuregulin on Experimental Dementia Model in Rats

I2 PP2A Regulates P53 and Akt Correlatively and Leads the Neurons to Abort Apoptosis

Neuregulin-1β Prevents Ca2+ Overloading and Apoptosis Through PI3K/Akt Activation in Cultured Dorsal Root Ganglion Neurons with Excitotoxicity Induced by Glutamate